Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
Date:7/30/2009

PITTSBURGH, July 30 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and six months ended June 30, 2009.

Financial Highlights

  • Adjusted diluted EPS, which excludes the impact of certain purchase accounting items as well as other non-cash and/or non-recurring items as detailed below, was $0.32 and $0.65 for the three and six months ended June 30, 2009, compared to $0.20 and $0.29 for the same prior year periods;
  • Total revenues of $1.27 billion for the three months ended June 30, 2009, an increase of $63.9 million over the same prior year period;
  • Total revenues of $2.48 billion for the six months ended June 30, 2009, an increase of $199.3 million over the same prior year period;
  • On a GAAP basis, the company reported diluted EPS of $0.19 and $0.42 for the three and six months ended June 30, 2009, compared to a loss per share of $0.05 and $1.52 in the same prior year periods. The six months ended June 30, 2008 included a non-cash goodwill impairment charge of $385.0 million related to the Specialty Segment.

Mylan's Chairman and CEO Robert J. Coury commented: "This was yet another successful quarter on many fronts for Mylan as, across the board, we delivered another quarter of financial performance that exceeded our expectations. Our powerful and integrated global platform enabled each of our businesses to generate year-over-year quarterly revenue growth on a constant currency basis and to deliver additional operational efficiencies as well. In addition, we took an important initial step in one of our targeted areas of future growth by entering into a collaborative agreement with Biocon in the area of generic biologics."


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
2. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
3. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
4. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
5. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
6. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
7. Mylan Confirms Four First-to-File Challenges
8. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
9. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
10. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 18, 2014 Reports from ... United States suffer from one or more chronic health ... cancer. Medication can address some of these diseases, but ... that many sufferers face. While implanted nerve stimulation devices ... the whole nerve, which can induce side effects. ...
(Date:12/19/2014)... With only 2 weeks left of ... Sartorius Biohit products . The product specials include Buy ... Pipette Trade-in Program, and free pipette tips. , Sartorius ... the world. They are ideal for lab technicians performing ... ,     Full volume range of 0.1 uL to ...
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... Houston, TX (PRWEB) December 17, 2014 ... marketing and administration for Stoller Group. In this position, ... Stoller Group, on administrative matters, develop marketing strategy and ... and services. , “Achim has tremendous knowledge and ... president of Stoller Group. “His experience and innovative thinking ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... Annual ... Scientific Session -, FREMONT, Calif., April ... company, presented data from a,study providing further confirmation that the Company,s ... The research suggests that such a panel may be useful in ...
... HUBBARD, Ohio, April 8, 2008 NanoLogix, Inc.,(OTC ... 2007 financial data and a director appointment., ... were,reduced by 42% over 2006, while funding for ... information can be accessed at:, http://www.nanologixinc.com/financials.html , ...
... Report,Transfer Across Disparate PACS and Maintains Hospital Group,s Operations as ... ... Crashes, SEATTLE, April 8, 2008 Compressus, leaders in,interoperability ... integrated digital imaging and data management,solution at E-Rad Solutions teleradiology ...
Cached Biology Technology:Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease 2Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease 3NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director 2Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers 2Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers 3
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
(Date:12/3/2014)... GLENDALE, Ariz. , Dec. 2, 2014 ... biometric hand readers, Inception Technologies is pleased to announce ... it easier for customers to collect the workforce data ... the problems that have been left by existing readers. ... to user interface, connectivity and modern technology. Older models ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2
... from NOAA and Texas A&M UniversityCorpus Christi were astounded to ... as some of the most common ocean habitats in the ... reverse previous beliefs about the prevalence of seamounts, which are ... coral reefs, most people will never see a seamount, but ...
... Governor Charlie Crist declared a state of emergency in ... for Southeastern Tropical Advanced Remote Sensing (CSTARS) at the ... international satellite data providers to acquire critical environmental imagery ... platform caught fire after an explosion on April 20 ...
... plants and science, nurtured by early days spent on her ... in the study of plants - and now to a ... work at Kansas State University. The five-year award will ... at K-State, to study how insects that serve as vectors ...
Cached Biology News:Scientists identify seamounts as significant, unexplored territory 2K-State scientist to receive $1 million CAREER award 2K-State scientist to receive $1 million CAREER award 3
CKB Antibody (N-term) Antigen: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected within aa 1~100 of human CKB. Molecular Weight: 42644 Da...
Anti-Digoxigenin-AP, Fab fragments; from sheep...
2 ml SmartScan Racks...
Request Info...
Biology Products: